November 8, 2026
SOHO 2026 Multiple Myeloma News News

CELMoDs in multiple myeloma: a decade of progress

CELMoDs represent the next generation of cereblon-binding agents specifically designed to address this challenge. Iberdomide and mezigdomide have demonstrated encouraging activity in heavily

Read More